BioSpace News Archive

Advances in scientific knowledge and drug development technology have provided an opportunity for new approaches to drug development, including the development of drugs for the trea

Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate virtually in the 39th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2021 . Geoff Martha , Medtronic chairman and chief executive officer, will make a formal presentation and answer questions on the company beginnin

Nearly 210,000 New York City students, teachers, principals and staff were tested by BioReference with a positivity rate of 0.47%

Lykan Bioscience, a contract Manufacturing Services Organization™ (MSO) and provider of the first true end-to-end solution for cell-based therapies, welcomes Patrick Lucy as President and Chief Operating Officer. With the Lykan Executive Team, Patrick will guide and drive the company’s continued rapid growth in the cell therapy

OrganaBio, LLC (“OrganaBio”) announces the launch of the ImmunoPAC™-T-CB T cell product, designed to support development of allogeneic immune cell-based therapies, such as CAR-T.

Leading health law firm McDermott Will & Emery, together with EY, is hosting its 2021 J.P. Morgan Healthcare Conference in four virtual sessions on January 7 and January 11-13, 2021.

Neos Therapeutics, Inc., a commercial-stage pharmaceutical company developing and manufacturing central nervous system-focused products, announced that Jerry McLaughlin, President and Chief Executive Officer, will participate in a pre-recorded presentation as part of the H.C. Wainwright Virtual BioConnect Conference.

Zosano Pharma Corporation, a clinical-stage biopharmaceutical company, announced that on December 30, 2020 the company requested a Type A meeting with the U.S. Food and Drug Administration.

Galecto, Inc., a NASDAQ listed biotechnology company focused on the development of novel treatments for fibrosis and cancer, announced that Hans Schambye, Chief Executive Officer, will participate in two panel discussions at the LifeSci Partners 10th Annual Healthcare Corporate Access Event, which is being held virtually from January 6-8 and 11-14.

Bioasis Technologies Inc. is pleased to announce that Dr. Deborah Rathjen, Executive Chair will be attending the following industry conferences:.